Analysis in The Lancet reveals the NHS must treat at least 10% more non-emergency cases monthly to reduce the pandemic-induced backlog, with over 7.2 million referrals pending as of October 2022.
Eli Lilly to acquire Morphic for $3.2 billion
Eli Lilly said Monday it will acquire Morphic Holding, a biotech developing a treatment for inflammatory bowel disease. Lilly will pay about $3.2 billion to